Literature DB >> 10720156

Tandem duplication of the FLT3 gene in acute lymphoblastic leukemia: a marker for the monitoring of minimal residual disease.

M Nakao, J W Janssen, D Erz, T Seriu, C R Bartram.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10720156     DOI: 10.1038/sj.leu.2401695

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  10 in total

Review 1.  Minimal residual disease quantitation in acute myeloid leukemia.

Authors:  David Shook; Elaine Coustan-Smith; Raul C Ribeiro; Jeffrey E Rubnitz; Dario Campana
Journal:  Clin Lymphoma Myeloma       Date:  2009

Review 2.  Potential role of sorafenib in the treatment of acute myeloid leukemia.

Authors:  Shahram Mori; Jorge Cortes; Hagop Kantarjian; Weiguo Zhang; Michael Andreef; Farhad Ravandi
Journal:  Leuk Lymphoma       Date:  2008-12

3.  Profiling gene mutations, translocations, and multidrug resistance in pediatric acute lymphoblastic leukemia: a step forward to personalizing medicine.

Authors:  Alphy Rose-James; R Shiji; P Kusumakumary; Manjusha Nair; Suraj K George; T T Sreelekha
Journal:  Med Oncol       Date:  2016-07-23       Impact factor: 3.064

Review 4.  Pediatric oncology.

Authors:  Raushan T Kurmasheva; Peter J Houghton
Journal:  Curr Opin Chem Biol       Date:  2007-07-24       Impact factor: 8.822

Review 5.  Flt3 in acute myelogenous leukemia: biology, prognosis, and therapeutic implications.

Authors:  Ioannis A Voutsadakis
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

6.  Monosomies 7p and 12p and FLT3 internal tandem duplication: possible markers for diagnosis of T/myeloid biphenotypic acute leukemia and its clonal evolution.

Authors:  Yosuke Matsumoto; Tomohiko Taki; Yoshiko Fujimoto; Kyoko Taniguchi; Daisuke Shimizu; Kazuho Shimura; Hitoji Uchiyama; Junya Kuroda; Kenichi Nomura; Tohru Inaba; Chihiro Shimazaki; Shigeo Horiike; Masafumi Taniwaki
Journal:  Int J Hematol       Date:  2009-03-24       Impact factor: 2.490

7.  FLT3-ITD Mutation and FLT3 Ligand Plasma Level Were Not Associated with One-Year Survival of Indonesian Acute Myeloid Leukemia Patients.

Authors:  Ikhwan Rinaldi; Melva Louisa; Resti Mulya Sari; Elly Arwanih
Journal:  Onco Targets Ther       Date:  2021-02-26       Impact factor: 4.147

Review 8.  Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implications.

Authors:  Shinichiro Takahashi
Journal:  J Hematol Oncol       Date:  2011-04-01       Impact factor: 17.388

9.  FLT3 Internal Tandem Duplication and D835 Mutations in Patients with Acute Lymphoblastic Leukemia and its Clinical Significance.

Authors:  Ghaleb Elyamany; Mohammed Awad; Omar Alsuhaibani; Kamal Fadalla; Omer Al Sharif; Mohammad Al Shahrani; Fahad Alabbas; Abdulaziz Al-Abulaaly
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-06-01       Impact factor: 2.576

10.  FLT3 activating mutations display differential sensitivity to multiple tyrosine kinase inhibitors.

Authors:  Bao Nguyen; Allen B Williams; David J Young; Hayley Ma; Li Li; Mark Levis; Patrick Brown; Donald Small
Journal:  Oncotarget       Date:  2017-02-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.